Journal Home > Volume 12 , Issue 1
Background

Mushrooms are a good source of many nutrients which are potentially beneficial for chronic diseases. We speculated that due to its abundant nutrients edible mushrooms might have a beneficial effect on the prevention of subclinical thyroid dysfunction (SCTD). Therefore, we designed a large-scale cohort study to examine whether mushrooms consumption is a protective factor for SCTD in adults.

Methods

This prospective cohort study investigated 6631 participants (mean age: (45.0 ± 10.2) years; 55.1% men). Edible mushrooms consumption was measured at baseline using a validated food frequency questionnaire. SCTD was defined as abnormal serum thyroid-stimulating hormone levels and normal free thyroxine. Cox proportional hazards regression models were used to examine the association of edible mushrooms consumption with incident SCTD.

Results

During follow-up period, a total of 262 new cases of SCTD were identified, the incidence rate of subclinical hypothyroidism was 8.9/1000 person-years and subclinical hyperthyroidism was 7.2/1000 person-years. After adjusting potential confounding factors, the multivariable hazard ratios (95% confidence intervals) for subclinical hypothyroidism were 1.00 (reference) for almost never, 0.53 (0.29, 0.97) for 1–3 times/week and 0.30 (0.10, 0.87) for ≥ 4 times/week (P for trend = 0.02). It also showed edible mushrooms consumption was inversely associated with subclinical hypothyroidism in obese individuals but not non-obese individuals, the final hazard ratios (95% confidence intervals) were 0.14 (0.03, 0.73) (P for trend < 0.01).

Conclusions

his population-based prospective cohort study has firstly demonstrated that higher edible mushrooms consumption was significantly associated with lower incidence of subclinical hypothyroidism among general adult population, especially in obese individuals.


menu
Abstract
Full text
Outline
About this article

Edible mushrooms as a potent therapeutics of subclinical thyroid dysfunction among adults, especially in obese individuals: a prospective cohort study

Show Author's information Juanjuan ZhangaSabina RayamajhiaAmrish ThapaaGe Menga,bQing ZhangcLi LiucHongmei WuaYeqing GudShunming ZhangaTingjing ZhangaXuena WangaZhixia CaoaJun DongaXiaoxi ZhengaXu ZhangaXinrong DongaXing WangcShaomei SuncMing ZhoucQiyu JiacKun SongcKaijun Niua,c,d,e,f( )
Nutritional Epidemiology Institute and School of Public Health, Tianjin Medical University, Tianjin 300070, China
Department of Toxicology and Sanitary Chemistry, School of Public Health, Tianjin Medical University, Tianjin 300070, China
Health Management Centre, Tianjin Medical University General Hospital, Tianjin 300070, China
Nutrition and Radiation Epidemiology Research Center, Institute of Radiation Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300192, China
Tianjin Key Laboratory of Environment, Nutrition and Public Health, Tianjin 300070, China
Center for International Collaborative Research on Environment, Nutrition and Public Health, Tianjin 300070, China

Peer review under responsibility of KeAi Communications Co., Ltd.

Abstract

Background

Mushrooms are a good source of many nutrients which are potentially beneficial for chronic diseases. We speculated that due to its abundant nutrients edible mushrooms might have a beneficial effect on the prevention of subclinical thyroid dysfunction (SCTD). Therefore, we designed a large-scale cohort study to examine whether mushrooms consumption is a protective factor for SCTD in adults.

Methods

This prospective cohort study investigated 6631 participants (mean age: (45.0 ± 10.2) years; 55.1% men). Edible mushrooms consumption was measured at baseline using a validated food frequency questionnaire. SCTD was defined as abnormal serum thyroid-stimulating hormone levels and normal free thyroxine. Cox proportional hazards regression models were used to examine the association of edible mushrooms consumption with incident SCTD.

Results

During follow-up period, a total of 262 new cases of SCTD were identified, the incidence rate of subclinical hypothyroidism was 8.9/1000 person-years and subclinical hyperthyroidism was 7.2/1000 person-years. After adjusting potential confounding factors, the multivariable hazard ratios (95% confidence intervals) for subclinical hypothyroidism were 1.00 (reference) for almost never, 0.53 (0.29, 0.97) for 1–3 times/week and 0.30 (0.10, 0.87) for ≥ 4 times/week (P for trend = 0.02). It also showed edible mushrooms consumption was inversely associated with subclinical hypothyroidism in obese individuals but not non-obese individuals, the final hazard ratios (95% confidence intervals) were 0.14 (0.03, 0.73) (P for trend < 0.01).

Conclusions

his population-based prospective cohort study has firstly demonstrated that higher edible mushrooms consumption was significantly associated with lower incidence of subclinical hypothyroidism among general adult population, especially in obese individuals.

Keywords: Edible mushrooms, Subclinical thyroid dysfunction, Obese individuals, Cohort study

References(44)

[1]

D.S. Cooper, B. Biondi, Subclinical thyroid disease, Lancet 379 (2012) 1142-1154. https://dx.doi.org/10.1016/s0140-6736(11)60276-6.

[2]

A.P. Delitala, A. Scuteri, M. Maioli, et al., Subclinical hypothyroidism and cardiovascular risk factors, Minerva Medica 110 (2019) 530-545. https://dx.doi.org/10.23736/s0026-4806.19.06292-x.

[3]

G. Huber, J.J. Staub, C. Meier, et al., Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies, J Clin Endocrinol Metab. 87 (2002) 3221-3226. https://dx.doi.org/10.1210/jcem.87.7.8678.

[4]

B. Biondi, D.S. Cooper. The clinical significance of subclinical thyroid dysfunction, Endocrine Reviews 29 (2008) 76-131. https://dx.doi.org/10.1210/er.2006-0043.

[5]

B. Biondi, A.R. Cappola, D.S. Cooper, Subclinical hypothyroidism: a review, Jama 322 (2019) 153-160. https://dx.doi.org/10.1001/jama.2019.9052.

[6]

G. Saravanan, P. Ponmurugan, Antidiabetic effect of S-allylcysteine: effect on thyroid hormone and circulatory antioxidant system in experimental diabetic rats, J. Diabetes Complications 26 (2012) 280-285. https://dx.doi.org/10.1016/j.jdiacomp.2012.03.024.

[7]

G. Cardwell, J.F. Bornman, A.P. James, et al., A review of mushrooms as a potential source of dietary vitamin D, Nutrients 10 (2018) 1498. https://dx.doi.org/10.3390/nu10101498.

[8]

D. Bikle, Nonclassic actions of vitamin D, The Journal of Clinical Endocrinology and Metabolism 94 (2009) 26-34. https://dx.doi.org/10.1210/jc.2008-1454.

[9]

B. Prietl, G. Treiber, T.R. Pieber, et al., Vitamin D and immune function, Nutrients 5 (2013) 2502-2521. https://dx.doi.org/10.3390/nu5072502.

[10]

S. Kivity, N. Agmon-Levin, M. Zisappl, et al., Vitamin D and autoimmune thyroid diseases, Cellular & Molecular Immunology 8 (2011) 243-247. https://dx.doi.org/10.1038/cmi.2010.73.

[11]

G. Tamer, S. Arik, I. Tamer, et al., Relative vitamin D insufficiency in Hashimoto's thyroiditis, Thyroid. 21 (2011) 891-896. https://dx.doi.org/10.1089/thy.2009.0200.

[12]

B. Hajioun, H. Jowhari, M. Mokhtari, Effects of cell phone radiation on the levels of T3, T4 and TSH, and histological changes in thyroid gland in rats treated with Allium sativum extract, Afr J Biotechnol. 13 (2014) 163-169. https://dx.doi.org/10.5897/ajb2013.12471.

[13]

L. Fan, L. Tan, Y. Chen, et al., Investigation on the factors that influence the prevalence of thyroid nodules in adults in Tianjin, China, J Trace Elem Med Biol. 50 (2018) 537-542. https://dx.doi.org/10.1016/j.jtemb.2018.03.004.

[14]

C.L.Z. Hou , Y. Cui, Y. Wang, et al., An investigation of iodine intake and iodine nutritional status of adults in Tianjin city[in Chinese], Chin J Endemiol. 35 (2016) 138-142.

[15]

P. Laurberg, C. Cerqueira, L. Ovesen, et al.. Iodine intake as a determinant of thyroid disorders in populations, Best Pract Res Clin Endocrinol Metab. 24 (2010) 13-27. https://dx.doi.org/10.1016/j.beem.2009.08.013.

[16]

S. Zhang, X. Wu, S. Bian, et al.. Association between consumption frequency of honey and non-alcoholic fatty liver disease: results from a cross-sectional analysis based on the TCLSIH Cohort study, Br J Nutr. 125(6) (2020) 1-25. https://dx.doi.org/10.1017/s0007114520003190.

[17]

L. Chaker, A.C. Bianco, J. Jonklaas, et al., Hypothyroidism, The Lancet 390 (2017) 1550-1562. https://dx.doi.org/10.1016/s0140-6736(17)30703-1.

[18]

Y. Gu, L. Zheng, Q. Zhang, et al., Relationship between thyroid function and elevated blood pressure in euthyroid adults, J Clin Hypertens (Greenwich). 20 (2018) 1541-1549. https://dx.doi.org/10.1111/jch.13369.

[19]

Q. Jia, Y. Xia, Q. Zhang, et al., Dietary patterns are associated with prevalence of fatty liver disease in adults, Eur J Clin Nutr. 69 (2015) 914-921. https://dx.doi.org/10.1038/ejcn.2014.297.

[20]

W. Willett, Nutritional epidemiology, third ed., Oxford. Oxford University Press, 2013.

[21]

Y. Yuexin, W. Guangya, P. Xingchang, China Food Composition, 2nd ed., Beijing, Peking University Medical Press, 2009.

[22]

K.G. Alberti, R.H. Eckel, S.M. Grundy, et al., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; american heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity, Circulation 120 (2009) 1640-1645. https://dx.doi.org/10.1161/circulationaha.109.192644.

[23]

C.L. Craig, A.L. Marshall, M. Sjöström, et al., International physical activity questionnaire: 12-country reliability and validity, Med Sci Sports Exerc. 35 (2003) 1381-1395. https://dx.doi.org/10.1249/01.mss.0000078924.61453.fb.

[24]

Y. Xia, Q. Xiang, Y. Gu, et al., A dietary pattern rich in animal organ, seafood and processed meat products is associated with newly diagnosed hyperuricaemia in Chinese adults: a propensity score-matched case-control study, Br J Nutr. 119 (2018) 1177-1184. https://dx.doi.org/10.1017/s0007114518000867.

[25]

C.H. Chang, Y.C. Yeh, J.L. Caffrey, et al., Metabolic syndrome is associated with an increased incidence of subclinical hypothyroidism - a cohort study, Sci Rep. 7 (2017) 6754. https://dx.doi.org/10.1038/s41598-017-07004-2.

[26]

T. Vadiveloo, P.T. Donnan, L. Cochrane, et al., The thyroid epidemiology, audit, and research study (TEARS): the natural history of endogenous subclinical hyperthyroidism, J Clin Endocrinol Metab. 96 (2011) E1-E8. https://dx.doi.org/10.1210/jc.2010-0854.

[27]

A. Gesing, A. Lewiński, M. Karbownik-Lewińska, The thyroid gland and the process of aging; what is new?, Thyroid Res. 5 (2012) 16. https://dx.doi.org/10.1186/1756-6614-5-16.

[28]

H. Abdi, E. Kazemian, S. Gharibzadeh, et al., Association between thyroid function and body mass index: a 10-year follow-up, Ann Nutr Metab. 70 (2017) 338-345. https://dx.doi.org/10.1159/000477497.

[29]

G.R.G. Andrade, B. Gorgulho, P.A. Lotufo, et al., Dietary selenium intake and subclinical hypothyroidism: a cross-sectional analysis of the elsa-brasil study, Nutrients 10 (2018) 693. https://dx.doi.org/10.3390/nu10060693.

[30]

Q. Wu, M.P. Rayman, H. Lv, et al., Low population selenium status is associated with increased prevalence of thyroid disease, J Clin Endocrinol Metab. 100 (2015) 4037-4047. https://dx.doi.org/10.1210/jc.2015-2222.

[31]

B. Muszyńska, K. Kała , J. Rojowski , et al., Composition and biological properties of Agaricus bisporusfruiting bodies - a review, Pol J Food Nutr Sci. 67 (2017) 1-10. https://dx.doi.org/10.1515/pjfns-2016-0032

[32]

R.J. Keegan, Z. Lu, J.M. Bogusz, et al., Photobiology of vitamin D in mushrooms and its bioavailability in humans, Dermato-Endocrinology 5 (2013) 165-176. https://dx.doi.org/10.4161/derm.23321.

[33]

S. Taheriniya, A. Arab, A. Hadi, et al., Vitamin D and thyroid disorders: a systematic review and Meta-analysis of observational studies, BMC Endocr Disord. 21 (2021) 171. https://dx.doi.org/10.1186/s12902-021-00831-5.

[34]

M. Feng, H. Li, S.F. Chen, et al., Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis, Endocrine 43 (2013) 318-326. https://dx.doi.org/10.1007/s12020-012-9812-y.

[35]

Q. Xiao, Y. Park, A.R. Hollenbeck, et al., Dietary flavonoid intake and thyroid cancer risk in the NIH-AARP diet and health study, Cancer Epidemiology, Biomarkers & Prevention 23 (2014) 1102-1108. https://dx.doi.org/10.1158/1055-9965.epi-13-1150.

[36]

E. Gaitan, R.H. Lindsay, R.D. Reichert, et al., Antithyroid and goitrogenic effects of millet: role of C-glycosylflavones, J Clin Endocrinol Metab. 68 (1989) 707-714. https://dx.doi.org/10.1210/jcem-68-4-707.

[37]

C. Roura-Mir, M. Catálfamo, M. Sospedra, et al., Single-cell analysis of intrathyroidal lymphocytes shows differential cytokine expression in Hashimoto’s and Graves’ disease, Eur J Immunol. 27 (1997) 3290-3302. https://dx.doi.org/10.1002/eji.1830271228.

[38]

N. Yamaguchi, J. Yoshida, L.J. Ren, et al., Augmentation of various immune reactivities of tumor-bearing hosts with an extract of Cordyceps sinensis, Biotherapy 2 (1990) 199-205. https://dx.doi.org/10.1007/bf02173520.

[39]

D. Wu, M. Pae, Z. Ren, et al., Dietary supplementation with white button mushroom enhances natural killer cell activity in C57BL/6 micem, J Nutr. 137 (2007) 1472-1477. https://dx.doi.org/10.1093/jn/137.6.1472.

[40]

M. Zarei, M. Zaeemi. Effects of testosterone enanthate treatment in conjunction with resistance training on thyroid hormones and lipid profile in male Wistar rats, Andrologia 50 (2018) 2. https://dx.doi.org/10.1111/and.12862.

[41]

O. Friedland, D. Nemet, N. Gorodnitsky, et al., Obesity and lipid profiles in children and adolescents, J Pediatr Endocrinol Metab. 15 (2002) 1011-1016. https://dx.doi.org/10.1515/jpem.2002.15.7.1011.

[42]

Y. Zhang, P. Lu, L. Zhang, et al., Association between lipids profile and thyroid parameters in euthyroid diabetic subjects: a cross-sectional study, BMC Endocr Disord. 15 (2015) 12. https://dx.doi.org/10.1186/s12902-015-0008-3.

[43]

S. Kanwal, S. Aliya, Y. Xin, Anti-obesity effect of dictyophora indusiata mushroom polysaccharide (DIP) in high fat diet-induced obesity via regulating inflammatory cascades and intestinal microbiome, Front Endocrinol. 11 (2020) 558-874. https://dx.doi.org/10.3389/fendo.2020.558874.

[44]

S.K. Dubey, V.K. Chaturvedi, D. Mishra, et al., Role of edible mushroom as a potent therapeutics for the diabetes and obesity, 3 Biotech 9 (2019) 450. https://dx.doi.org/10.1007/s13205-019-1982-3.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 10 August 2021
Revised: 07 September 2021
Accepted: 10 October 2021
Published: 09 August 2022
Issue date: January 2023

Copyright

© 2023 Beijing Academy of Food Sciences. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.

Acknowledgements

This study was supported by grants from the National Natural Science Foundation of China (81941024), Tianjin Major Public Health Science and Technology Project (21ZXGWSY00090), National Health Commission of China (SPSYYC 2020015), Food Science and Technology Foundation of Chinese Institute of Food Science and Technology (2019-12), 2014 and 2016 Chinese Nutrition Society (CNS) Nutrition Research Foundation -DSM Research Fund (2016-046, 2014-071 and 2016-023), China.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Return